The two faces of embryonic stem cells

By Tim Dean
Wednesday, 26 May, 2010


Embryonic stem (ES) cells - those karyotypically normal immortal cell lines that can give rise to all other cell types of that organism - are believed to hold great promise for therapeutic applications.

But before we find a way to apply ES cells, we need to know precisely what they are. And new study from researchers at the University of Edinburgh has found that ES cells are actually a mix of two types of stem cells.

The researchers used a fluorescent reporter cell line to visualise individual stem cells based on the markers they express and were able to identify two different groups of cells.

While both were found to have all the properties of ES cells, when encouraged to differentiate, they each had a strong lineage bias, with some going down the line expected of ES cells, while the others becoming primitive endoderm cells - which are involved in the creation of the placenta.

It appears that, in their natural environment, ES cells respond to signals from surrounding cells, which inform them on which type of cell to become, quickly fixing to become only one type.

However, in the laboratory, these signals are absent, and the cells remain unfixed.

"This study changes our view of what embryonic stem cells are and how they behave," said Dr Josh Brickman, from Edinburgh University's Medical Research Council Centre for Regenerative Medicine.

"Knowing that embryonic stem cells can switch between different founder cell types could help us isolate cells at a point in time when they are primed to become specific cells. This could improve the ability to produce specific cells in the laboratory."

The study was published online in PLoS Biology, doi:10.1371/journal.pbio.1000379.

Related Articles

AI-designed DNA switches flip genes on and off

The work creates the opportunity to turn the expression of a gene up or down in just one tissue...

Drug delays tumour growth in models of children's liver cancer

A new drug has been shown to delay the growth of tumours and improve survival in hepatoblastoma,...

Ancient DNA rewrites the stories of those preserved at Pompeii

Researchers have used ancient DNA to challenge long-held assumptions about the inhabitants of...


  • All content Copyright © 2024 Westwick-Farrow Pty Ltd